30-Day No-Hassle Returns
We guarantee your satisfaction on every purchase or rental with a full refund within 30 days of your purchase date.
Fast, Same-Day Customer Service
If you need help, our friendly, helpful Customer Service team will contact you the same business day.
The Best Prices on Textbook Rentals, Guaranteed
You can shop with confidence with the best rental prices at ValoreBooks.com. If you find a lower priced rental, we will match it.
See the full guarantee details

Better Pharmaceuticals for Children Assessment and Opportunities Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate One Hundred Seventh Congress,

by

Jeffords, James M.

OUT OF STOCK - We are increasing our inventory daily! - Please try again later.
Better Pharmaceuticals for Children Assessment and Opportunities Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate One Hundred Seventh Congress,, ISBN 9780756727536 Own This Book? Sell It
ISBN-13:

9780756727536

ISBN:

0756727537

Publisher: DIANE Publishing Company Summary: Assesses the impact of the pediatric exclusivity provision granting a pharmaceutical co. an additional 6 months of market exclusivity for new or marketed drugs in exchange for conducting pediatric studies requested by the FDA. The hearing was held before the provision was set to expire on Jan. 1, 2002. Witnesses: Janet Woodcock, Center for Drug Eval. & Res., FDA; Janet Heinrich, Public Health Issues, GAO; Robert Ward [read more]
THE EXTRA MILE GUARANTEE
  • 30-Day No-Hassle Returns
  • Fast, Same-Day Customer Service
  • The Best Prices on Textbook Rentals
Read More
NEED HELP PAYING FOR COLLEGE?
  • Find student loan options quickly and easily
  • Compare loans to find the best fit for you
  • Apply for the loan that meets your needs
Find Loan
Product Details
ISBN-13:

9780756727536


ISBN:

0756727537


Publisher: DIANE Publishing Company

Assesses the impact of the pediatric exclusivity provision granting a pharmaceutical co. an additional 6 months of market exclusivity for new or marketed drugs in exchange for conducting pediatric studies requested by the FDA. The hearing was held before the provision was set to expire on Jan. 1, 2002. Witnesses: Janet Woodcock, Center for Drug Eval. & Res., FDA; Janet Heinrich, Public Health Issues, GAO; Robert Ward, Comm. on Drugs, Amer. Acad. of Pediatrics; Stephen Spielberg, Pediatric Drug Dev't., Janssen Pharmaceut.; John Golenski, RX Health Value; Larry McAndrews, Nat. Assoc. of Children's Hosp.; John Mahan, Children's Hosp., Columbus, OH. Prepared state.: Amer. Acad. of Child & Adol. Psych., & Generic Pharm. Assoc.

Where's My Stuff?
Shipping & Returns
Need Help?